Relay Therapeutics (NASDAQ:RLAY – Get Free Report) announced its earnings results on Thursday. The company reported ($0.67) EPS for the quarter, beating analysts’ consensus estimates of ($0.76) by $0.09, Briefing.com reports. Relay Therapeutics had a negative net margin of 1,263.49% and a negative return on equity of 38.10%. During the same period in the previous […]
Relay Therapeutics (NASDAQ:RLAY – Free Report) had its price objective lowered by HC Wainwright from $19.00 to $17.00 in a research report released on Monday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Relay Therapeutics Stock Up 5.8 % RLAY stock opened at $10.08 on Monday. Relay Therapeutics has a 52 […]
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong […]
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the […]
Relay Therapeutics (NASDAQ:RLAY – Get Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.83) per share for the quarter. Relay Therapeutics (NASDAQ:RLAY – Get Free Report) last posted its quarterly earnings data on Tuesday, August 8th. The company […]